Astrazeneca Plc (AZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 12-1999 | 12-1998 | 12-1997 | 12-1996 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 4,330,000 | 0 | 0 | 0 | N/A |
| Depreciation Amortization | 988,000 | 0 | 0 | 0 | N/A |
| Other Working Capital | 340,000 | 0 | 0 | 0 | N/A |
| Other Operating Activity | -1,475,000 | 2,125,000 | 0 | 0 | 0 |
| Operating Cash Flow | $4,183,000 | $2,125,000 | $0 | $0 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,423,000 | 0 | 0 | 0 | N/A |
| Net Acquisitions | -2,000 | 0 | 0 | 0 | N/A |
| Other Investing Activity | -1,103,000 | -1,216,000 | 0 | 0 | 0 |
| Investing Cash Flow | $-2,528,000 | $-1,216,000 | $0 | $0 | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -400,000 | -182,000 | 0 | 0 | 0 |
| Financing Cash Flow | $-400,000 | $-182,000 | $0 | $0 | $N/A |
| Net Cash Flow | $640,000 | $-280,000 | $0 | $0 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | 4,183,000 | 2,125,000 | 0 | 0 | N/A |
| Free Cash Flow | 4,183,000 | 2,125,000 | 0 | 0 | 0 |